Prevalence of somatoform disorders and medically unexplained symptoms in old age populations in comparison with younger age groups: A systematic review

被引:127
作者
Hilderink, P. H. [1 ]
Collard, R. [2 ,3 ]
Rosmalen, J. G. M. [4 ,5 ]
Voshaar, R. C. Oude [4 ,5 ]
机构
[1] Pro Persona Ctr Integrat Mental Hlth Care, Div Old Age Psychiat, Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Evidence Based Practice, Nijmegen, Netherlands
[4] Univ Groningen, Univ Ctr Psychiat, Groningen, Netherlands
[5] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Pathol Emot, Groningen, Netherlands
关键词
Somatoform disorders; Medically unexplained symptoms; Old age; Epidemiology; PRIMARY-CARE PATIENTS; GENERAL-PRACTICE; SOMATIZATION DISORDER; PSYCHIATRIC-DISORDERS; MAJOR DEPRESSION; MENTAL-DISORDERS; RISK-FACTORS; PHYSICAL SYMPTOMS; SOMATIC SYMPTOMS; HYPOCHONDRIASIS;
D O I
10.1016/j.arr.2012.04.004
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Objective: To review current knowledge regarding the prevalence of somatization problems in later life by level of caseness (somatoform disorders and medically unexplained symptoms, MUS) and to compare these rates with those in middle-aged and younger age groups. Method: A systematic search of the literature published from 1966 onwards was conducted in the Pubmed and EMBASE databases. Results: Overall 8 articles, describing a total of 7 cohorts, provided data of at least one prevalence rate for somatoform disorders or MUS for the middle-aged (50-65 years) or older age (>= 65 years) group. Prevalence rates for somatoform disorders in the general population range from 11 to 21% in younger, 10 to 20% in the middle-aged, and 1.5 to 13% in the older age groups. Prevalence rates for MUS show wider ranges, of respectively 1.6-70%, 2.4-87%, and 4.6-18%, in the younger, middle, and older age groups, which could be explained by the use of different instruments as well as lack of consensus in defining MUS. Conclusion: Somatoform disorders and MUS are common in later life, although the available data suggest that prevalence rates decline after the age of 65 years. More systematic research with special focus on the older population is needed to understand this age-related decline in prevalence rates. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:151 / 156
页数:6
相关论文
共 55 条
[1]
[Anonymous], 1992, J AM MED ASS, V268, P3098
[2]
Mental disorders associated with benzodiazepine use among older primary care attenders - A regional survey [J].
Balestrieri, M ;
Marcon, G ;
Samani, F ;
Marini, M ;
Sessa, E ;
Gelatti, U ;
Donato, F .
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2005, 40 (04) :308-315
[3]
Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity [J].
Barsky, AJ ;
Orav, EJ ;
Bates, DW .
ARCHIVES OF GENERAL PSYCHIATRY, 2005, 62 (08) :903-910
[4]
Major and minor depression in later life: A study of prevalence and risk factors [J].
Beekman, ATF ;
Deeg, DJH ;
vanTilburg, T ;
Smit, JH ;
Hooijer, C ;
vanTilburg, W .
JOURNAL OF AFFECTIVE DISORDERS, 1995, 36 (1-2) :65-75
[5]
Benraad C., PHYS FUNCTIONI UNPUB
[6]
Burton C, 2003, BRIT J GEN PRACT, V53, P231
[7]
Somatic symptoms, hypochondriasis and psychological distress: a study of somatisation in Australian general practice [J].
Clarke, David M. ;
Piterman, Leon ;
Byrne, Claire J. ;
Austin, David W. .
MEDICAL JOURNAL OF AUSTRALIA, 2008, 189 (10) :560-564
[8]
The treatment of common mental disorders across age groups: Results from the 2007 adult psychiatric morbidity survey [J].
Cooper, Claudia ;
Bebbington, Paul ;
McManus, Sally ;
Meltzer, Howard ;
Stewart, Robert ;
Farrell, Michael ;
King, Michael ;
Jenkins, Rachel ;
Livingston, Gill .
JOURNAL OF AFFECTIVE DISORDERS, 2010, 127 (1-3) :96-101
[9]
A systematic review of the epidemiology of somatisation disorder and hypochondriasis [J].
Creed, F ;
Barsky, A .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 2004, 56 (04) :391-408
[10]
Somatoform disorders in general practice - Prevalence, functional impairment and comorbidity with anxiety and depressive disorders [J].
De Waal, MWM ;
Arnold, IA ;
Eekhof, JAH ;
Van Hemert, AM .
BRITISH JOURNAL OF PSYCHIATRY, 2004, 184 :470-476